Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Maurenis Hernández"'
Autor:
Kirenia Camacho Sosa, Mayra Ramos Suzarte, Carmen Elena Viada González, Elia Nenínger Vinageras, Eduardo Rafael Santiesteban Álvarez, Maurenis Hernández Pérez, Yoanna Ivette Flores Vega, Saylin Alfonso Alemán, Ramón Alberto Ortiz Carrodeguas, Soraida Candida Acosta Brooks, Pedro Pablo Guerra Chaviano, Ivis Mendoza Hernández, Tania Crombet Ramos, Agustín Lage Dávila
Publikováno v:
Revista Cubana de Medicina Militar, Vol 52, Iss 3, Pp e02303004-e02303004 (2023)
Introduction: The response to therapies in advanced lung cancer could be related to certain prognostic factors such as inflammatory indices. Objective: To evaluate the efficacy of the humanized monoclonal antibody nimotuzumab in patients with advance
Externí odkaz:
https://doaj.org/article/e192693e6d24410daf2fcef4ca8c7838
Autor:
Amparo E. Macías, Ana María Vázquez, Rolando Pérez, Tania Crombet, Zaima Mazorra, Zuyén González, Darien Toledo, Ana María Hernández, Eric Chong, Kirenia Pérez, Meylán Cepeda, Ana V. de la Torre, Ramón A. Ortiz, Elena García, Pedro P. Guerra, Ivis C. Mendoza, Carmen E. Viada, Maurenis Hernández, Fernando Areces, Yoanna I. Flores, Eduardo R. Santiesteban, Anet Valdés-Zayas, Sailyn Alfonso
PDF file - 284KB, CONSORT study diagram.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60661ba2a8843d50bd85fdb4eb676e6d
https://doi.org/10.1158/1078-0432.22446792
https://doi.org/10.1158/1078-0432.22446792
Autor:
Amparo E. Macías, Ana María Vázquez, Rolando Pérez, Tania Crombet, Zaima Mazorra, Zuyén González, Darien Toledo, Ana María Hernández, Eric Chong, Kirenia Pérez, Meylán Cepeda, Ana V. de la Torre, Ramón A. Ortiz, Elena García, Pedro P. Guerra, Ivis C. Mendoza, Carmen E. Viada, Maurenis Hernández, Fernando Areces, Yoanna I. Flores, Eduardo R. Santiesteban, Anet Valdés-Zayas, Sailyn Alfonso
PDF file - 61KB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1deb9012efb687f159146fcfb489b73d
https://doi.org/10.1158/1078-0432.22446786.v1
https://doi.org/10.1158/1078-0432.22446786.v1
Autor:
Amparo E. Macías, Ana María Vázquez, Rolando Pérez, Tania Crombet, Zaima Mazorra, Zuyén González, Darien Toledo, Ana María Hernández, Eric Chong, Kirenia Pérez, Meylán Cepeda, Ana V. de la Torre, Ramón A. Ortiz, Elena García, Pedro P. Guerra, Ivis C. Mendoza, Carmen E. Viada, Maurenis Hernández, Fernando Areces, Yoanna I. Flores, Eduardo R. Santiesteban, Anet Valdés-Zayas, Sailyn Alfonso
PDF file - 2804KB, Association of antibody response with patient's survival.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bd09b753c0d34f30da445a1a0dbe7c7
https://doi.org/10.1158/1078-0432.22446771
https://doi.org/10.1158/1078-0432.22446771
Autor:
Amparo E. Macías, Ana María Vázquez, Rolando Pérez, Tania Crombet, Zaima Mazorra, Zuyén González, Darien Toledo, Ana María Hernández, Eric Chong, Kirenia Pérez, Meylán Cepeda, Ana V. de la Torre, Ramón A. Ortiz, Elena García, Pedro P. Guerra, Ivis C. Mendoza, Carmen E. Viada, Maurenis Hernández, Fernando Areces, Yoanna I. Flores, Eduardo R. Santiesteban, Anet Valdés-Zayas, Sailyn Alfonso
Purpose: Racotumomab-alum is an anti-idiotype vaccine targeting the NeuGcGM3 tumor-associated ganglioside. This clinical trial was conducted to provide a preliminary estimate of efficacy and safety of racotumomab as switch maintenance for patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a606512ef5ea47aa6c0cf297ef32478
https://doi.org/10.1158/1078-0432.c.6520869.v1
https://doi.org/10.1158/1078-0432.c.6520869.v1
Autor:
Amparo E. Macías, Ana María Vázquez, Rolando Pérez, Tania Crombet, Zaima Mazorra, Zuyén González, Darien Toledo, Ana María Hernández, Eric Chong, Kirenia Pérez, Meylán Cepeda, Ana V. de la Torre, Ramón A. Ortiz, Elena García, Pedro P. Guerra, Ivis C. Mendoza, Carmen E. Viada, Maurenis Hernández, Fernando Areces, Yoanna I. Flores, Eduardo R. Santiesteban, Anet Valdés-Zayas, Sailyn Alfonso
PDF file - 47KB, Adverse event severity.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df1d99a5fb93b113837a98c7006a8a25
https://doi.org/10.1158/1078-0432.22446783.v1
https://doi.org/10.1158/1078-0432.22446783.v1
Autor:
Amparo E. Macías, Ana María Vázquez, Rolando Pérez, Tania Crombet, Zaima Mazorra, Zuyén González, Darien Toledo, Ana María Hernández, Eric Chong, Kirenia Pérez, Meylán Cepeda, Ana V. de la Torre, Ramón A. Ortiz, Elena García, Pedro P. Guerra, Ivis C. Mendoza, Carmen E. Viada, Maurenis Hernández, Fernando Areces, Yoanna I. Flores, Eduardo R. Santiesteban, Anet Valdés-Zayas, Sailyn Alfonso
PDF file - 132KB, Number of doses received, maximal titer and isotype analysis against Racotumomab-mAb and NeuGcGM3, percentages of binding and cytotoxicity against L1210 cells, and survival times in vaccinated NSCLC patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02cb2fc69f59299e4d9f59c6f8eeaee4
https://doi.org/10.1158/1078-0432.22446777.v1
https://doi.org/10.1158/1078-0432.22446777.v1
Autor:
Amparo E. Macías, Ana María Vázquez, Rolando Pérez, Tania Crombet, Zaima Mazorra, Zuyén González, Darien Toledo, Ana María Hernández, Eric Chong, Kirenia Pérez, Meylán Cepeda, Ana V. de la Torre, Ramón A. Ortiz, Elena García, Pedro P. Guerra, Ivis C. Mendoza, Carmen E. Viada, Maurenis Hernández, Fernando Areces, Yoanna I. Flores, Eduardo R. Santiesteban, Anet Valdés-Zayas, Sailyn Alfonso
PDF file - 66KB, Summary of adverse events.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19ac1e7dd3de32d9c423d22f39332f15
https://doi.org/10.1158/1078-0432.22446780
https://doi.org/10.1158/1078-0432.22446780
Autor:
Amparo E. Macías, Ana María Vázquez, Rolando Pérez, Tania Crombet, Zaima Mazorra, Zuyén González, Darien Toledo, Ana María Hernández, Eric Chong, Kirenia Pérez, Meylán Cepeda, Ana V. de la Torre, Ramón A. Ortiz, Elena García, Pedro P. Guerra, Ivis C. Mendoza, Carmen E. Viada, Maurenis Hernández, Fernando Areces, Yoanna I. Flores, Eduardo R. Santiesteban, Anet Valdés-Zayas, Sailyn Alfonso
PDF file - 137KB, Association of functional capacity of elicited anti-NeuGcGM3 antibodies with patient's survival.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dda254ca2410c9cf708ad664ad92125
https://doi.org/10.1158/1078-0432.22446768.v1
https://doi.org/10.1158/1078-0432.22446768.v1
Autor:
Amparo E. Macías, Ana María Vázquez, Rolando Pérez, Tania Crombet, Zaima Mazorra, Zuyén González, Darien Toledo, Ana María Hernández, Eric Chong, Kirenia Pérez, Meylán Cepeda, Ana V. de la Torre, Ramón A. Ortiz, Elena García, Pedro P. Guerra, Ivis C. Mendoza, Carmen E. Viada, Maurenis Hernández, Fernando Areces, Yoanna I. Flores, Eduardo R. Santiesteban, Anet Valdés-Zayas, Sailyn Alfonso
PDF file - 144KB, Overall survival HRs (racotumomab over placebo) in subgroups according to baseline characteristics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02263a739e5a43d4c4053c07afdfb39c
https://doi.org/10.1158/1078-0432.22446789.v1
https://doi.org/10.1158/1078-0432.22446789.v1